Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11965159
Compositions and methods for regulating proteins and nucleic acids activities
granted -
US 11965190
Vectors, genetically modified bacteria, and methods of making and using
granted -
US 11964025
Peptide-containing linkers for antibody-drug conjugates
granted -
US 11964021
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted -
US 11964047
Ophthalmic formulations and related methods
granted -
US 11964010
Prefusion coronavirus spike proteins and their use
granted -
US 11964016
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
granted -
US 11964018
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11964985
Anti-cancer compounds targeting Ral GTPases and methods of using the same
granted -
US 11963970
Preparation method of ginseng composition with high ginsenoside bioavailability
granted -
US 11963953
Deuterated compounds for restoring mutant p53 function
granted -
US 11963981
Chimeric antigen receptor
granted -
US 11963982
CRISPR/RNA-guided nuclease systems and methods
granted -
US 11965020
Antigen binding molecule formats
granted -
US 11964003
Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same
granted -
US 11963959
Inhibitors for coronavirus
granted -
US 11965017
Serpin fusion polypeptides and methods of use thereof
granted -
US 11963958
RET inhibitor for use in treating cancer having a RET alteration
granted -
US 11964000
Cancer treatment methods using nanofiber stabilized growth factors
granted -
US 11965022
Methods and compositions for modulating CAR-T activity
granted -
US 11965161
Methods and compositions for sensitization of tumor cells to immune therapy
granted -
WO 2024081718
ANTAGONISTE DU RÉCEPTEUR CGRP POUR LE TRAITEMENT DE LA MIGRAINE
granted -
CA 3268414
MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS
granted -
US 11959096
Methods for selective inhibition of pluripotent stem cells
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.